![]() Catalent Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products. | WuXi Biologics WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development. | |
Founding Date | Founding Date 2007 | Founding Date 2010 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Bridgewater, US HQ Buenos Aires, AR Bruxelles, BE Charleroi, BE Charleroi, BE Charleroi, BE Indaiatuba, BR see more | Locations Wuxi, CN HQ George Town, KY Wuppertal, DE Hong Kong, HK Dundalk, IE Cranbury, US King Of Prussia, US |
Employees | Employees 12,6955% increase | Employees 12,575 |
Financial | ||
Revenue (est.) | Revenue (est.) $4.4b (FY, 2024) | Revenue (est.) ¥21.8b (FY, 2025) |
Cost of goods | Cost of goods $3.4b (FY, 2024) | Cost of goods ¥10b (FY, 2025) |
Gross profit | Gross profit $953m (FY, 2024) | Gross profit ¥12b (FY, 2025) |
Net income | Net income ($1b) (FY, 2024) | Net income ¥5.7b (FY, 2025) |
Operating ⚠ | ||
Backlog | Backlog $2.5b (FY, 2023) | Backlog $18.5b (H1, 2022) |
WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development.
View company